| Exercise Effects in Multiple Sclerosis (NCT05496881) | University of Regina | 2022-06-15 |
| Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS (NCT03799718) | Brainstorm-Cell Therapeutics | 2019-03-13 |
| Sensitivity of Motor Assessment in MS - a Prospective Cohort Study (NCT04993274) | Friedemann Paul | 2019-02-20 |
| Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients (NCT04550650) | Somogy Megyei Kaposi Mór Teaching Hospital | 2018-04-06 |
| The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients (NCT03424538) | Somogy Megyei Kaposi Mór Teaching Hospital | 2018-02-05 |
| Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) (NCT02903537) | Fundació Institut Germans Trias i Pujol | 2017-07-06 |
| Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS (NCT03114293) | Universitätsklinikum Hamburg-Eppendorf | 2016-04-01 |
| Intrathecal Rituximab in Progressive Multiple Sclerosis (NCT02545959) | Centre Hospitalier de PAU | 2015-11-30 |
| Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis (NCT02403570) | Turku University Hospital | 2015-02-01 |
| China Betaferon Adherence, Coping and Nurse Support Study (NCT01436838) | Bayer | 2012-03-01 |
| Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) (NCT01188811) | VA Office of Research and Development | 2010-10-01 |
| Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis (NCT00411723) | Artielle ImmunoTherapeutics | 2006-12-01 |
| Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (NCT00241254) | University Hospital, Bordeaux | 2005-12-01 |
| Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients (NCT00220493) | Sheba Medical Center | 2003-06-01 |